PO Ixazomib in Combination With Chemotherapy for Childhood Relapsed or Refractory Acute Lymphoblastic Leukemia and Lymphoblastic Lymphoma

NCT03817320 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

ACTIVE_NOT_RECRUITING

Status

24

Enrollment

OTHER

Sponsor class

Conditions

ALL, Childhood
Lymphoblastic Lymphoma, Childhood
Lymphoblastic Leukemia, Acute, Childhood

Interventions

DRUG: Ixazomib
DRUG: Vincristine
DRUG: Dexamethasone
DRUG: Asparaginase
DRUG: Doxorubicin
DRUG: Methotrexate (IT)
DRUG: Triple IT (Methotrexate, Hydrocortisone, Cytarabine)
DRUG: Leucovorin

Sponsor

Therapeutic Advances in Childhood Leukemia Consortium

Collaborators

[object Object]
[object Object]